Search research articles
Contact Us
Filters
Showing results (261-270 of 1,278) with videos related to
Page
of 128
Sort By:
Annals of Neurology
|
May 9, 2020
SARS-CoV-2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad
Sandra Amor, David Baker, Samia J Khoury, et al.
The European Journal of Neuroscience
|
November 5, 2004
Cannabinoid-mediated neuroprotection following interferon-gamma treatment in a three-dimensional mouse brain aggregate cell culture
Samuel J Jackson, David Baker, M Louise Cuzner, et al.
Proteins
|
April 23, 2004
Modeling structurally variable regions in homologous proteins with rosetta
Carol A Rohl, Charlie E M Strauss, Dylan Chivian, et al.
The American Journal of Emergency Medicine
|
October 3, 2003
Use of dosage as a triage guideline for unintentional cyclic antidepressant (UCA) ingestions in children
Henry A Spiller, S David Baker, Edward P Krenzelok, et al.
Multiple Sclerosis and Related Disorders
|
July 10, 2020
The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis
David Baker, Gareth Pryce, Louisa K James, et al.
The Plant Journal : for Cell and Molecular Biology
|
August 19, 2011
Two high linolenic mutants of Arabidopsis thaliana contain megabase-scale genome duplications encompassing the FAD3 locus
Carmel M O'Neill, David Baker, Gawain Bennett, et al.
Proteins
|
September 16, 2017
Automatic structure prediction of oligomeric assemblies using Robetta in CASP12
Hahnbeom Park, David E Kim, Sergey Ovchinnikov, et al.
Proteins
|
September 24, 2017
Protein structure prediction using Rosetta in CASP12
Sergey Ovchinnikov, Hahnbeom Park, David E Kim, et al.
Plos Currents
|
November 13, 2012
Health impacts of wildfires
Sarah Elise Finlay, Andrew Moffat, Rob Gazzard, et al.
Proteins
|
April 14, 2011
Structure-guided forcefield optimization
Yifan Song, Michael Tyka, Andrew Leaver-Fay, et al.
Page
of 128
Search research articles
Search
Showing results (261-270 of 1,278) with videos related to
Sort By:
Page
of 128
Annals of Neurology
|
May 9, 2020
SARS-CoV-2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad
Sandra Amor, David Baker, Samia J Khoury, et al.
The European Journal of Neuroscience
|
November 5, 2004
Cannabinoid-mediated neuroprotection following interferon-gamma treatment in a three-dimensional mouse brain aggregate cell culture
Samuel J Jackson, David Baker, M Louise Cuzner, et al.
Proteins
|
April 23, 2004
Modeling structurally variable regions in homologous proteins with rosetta
Carol A Rohl, Charlie E M Strauss, Dylan Chivian, et al.
The American Journal of Emergency Medicine
|
October 3, 2003
Use of dosage as a triage guideline for unintentional cyclic antidepressant (UCA) ingestions in children
Henry A Spiller, S David Baker, Edward P Krenzelok, et al.
Multiple Sclerosis and Related Disorders
|
July 10, 2020
The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis
David Baker, Gareth Pryce, Louisa K James, et al.
The Plant Journal : for Cell and Molecular Biology
|
August 19, 2011
Two high linolenic mutants of Arabidopsis thaliana contain megabase-scale genome duplications encompassing the FAD3 locus
Carmel M O'Neill, David Baker, Gawain Bennett, et al.
Proteins
|
September 16, 2017
Automatic structure prediction of oligomeric assemblies using Robetta in CASP12
Hahnbeom Park, David E Kim, Sergey Ovchinnikov, et al.
Proteins
|
September 24, 2017
Protein structure prediction using Rosetta in CASP12
Sergey Ovchinnikov, Hahnbeom Park, David E Kim, et al.
Plos Currents
|
November 13, 2012
Health impacts of wildfires
Sarah Elise Finlay, Andrew Moffat, Rob Gazzard, et al.
Proteins
|
April 14, 2011
Structure-guided forcefield optimization
Yifan Song, Michael Tyka, Andrew Leaver-Fay, et al.
Page
of 128